Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Effects of $(1R,9S)-{\beta}-Hydrastine$ hydrochloride on L-DOPA-Induced Cytotoxicity in PC12 cells

  • Yin, Shou-Yu (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University,College of Pharmacy, Yanbian University) ;
  • Lee, Jae-Joon (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Kim, Yu-Mi (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Jin, Chun-Mei (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Yang, Yoo-Jung (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) ;
  • Lee, Myung-Koo (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University)
  • Published : 2004.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Previously, $(1R,9S)-{\beta}-Hydrastine$ hydrochloride has been found to lower dopamine content in PC12 cells (Kim et al., 20001). In this study, the effects of $(1R,9S)-{\beta}-Hydrastine$ hydrochloride on L-DOPA-induced cytotoxicity in PC12 cells were investigated. Treatment with $(1R,9S)-{\beta}-Hydrastine$ hydrochloride at concentrations higher than $500\;{\mu}M$ caused cytotoxicity in PC12 cells. In addition, $(1R,9S)-{\beta}-Hydrastine$ hydrochloride at non-cytotoxic or cytotoxic concentrations significantly enhanced L-DOPA-induced cytotoxicity (L-DOPA concentration, $50\;{\mu}M$). Treatment of PC12 cells with $750\;{\mu}M$ $-1R,9S)-{\beta}-Hydrastine$ hydrochloride and $50\;{\mu}M$ L-DOPA, alone or in combination, also induced cell death via a mechanism which exhibited morphological and biochemical characteristics of apoptosis, including chromatin condensation and membrane blebbing. Exposure of PC12 cells to $(1R,9S)-{\beta}-Hydrastine$ hydrochloride, L-DOPA and $(1R,9S)-{\beta}-Hydrastine$ hydrochloride plus L-DOPA for 48 h resulted in a marked increase in the cell loss and percentage of apoptotic cells compared with exposure for 24 h. These data indicate that $(1R,9S)-{\beta}-Hydrastine$hydrochloride at higher concentration ranges aggravates L-DOPA-induced neurotoxicity cytotoxicity in PC12 cells. Therefore, it is proposed that the long-term L-DOPA therapeutic patients with $(1R,9S)-{\beta}-Hydrastine$ hydrochloride could be checked for the adverse symptoms.

Keywords

References

  1. Basma, A.N., Morris, E.J., Nicklas, W.J., and Geller, H.M., L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem., 64, 825-832 (1995) https://doi.org/10.1046/j.1471-4159.1995.64020825.x
  2. Desole, M.S., Sciola, L., Delogu, M.R., Siricana, R., and Migheli, R., Manganese and 1-methyl-4-(2'-ethylpheyl)-1,2,3,6-tetrahy-dropyridine induce apoptosis in PC12 cells. Neurosci., 209, 193-196 (1996) https://doi.org/10.1016/0304-3940(96)12645-8
  3. Graham, D.C., Tiffany, S.M., Bell, W.R Jr., and Gutknecht, W.F., Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol., 14, 644-653 (1978)
  4. Greene, L.A. and Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA, 73, 2424-2428 (1976) https://doi.org/10.1073/pnas.73.7.2424
  5. Itano, Y., Kitamura, Y., and Nomure, Y., 1-Methyl-4-phenylpyridinium (MPP$^+$)-induced cell death in PC12 cells: inhibitory effects of several drugs. Neurochem. Int., 25, 419-424 (1994) https://doi.org/10.1016/0197-0186(94)90017-5
  6. Kikuchi, K., Nagatsu, Y., Makino, Y., Mashino, T., Ohta, S., and Hirobe, M., Metabolism and penetration through the blood-brain barrier of parkinsonism-related compounds: 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Drug Metab. Dispos., 19, 257-262 (1991)
  7. Kim, S.H., Shin, J.S., Lee, J.J., Yin, S.Y., Kai, M., and Lee, M.K., Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med., 67, 609-613 (2001) https://doi.org/10.1055/s-2001-17356
  8. Kotake, Y., Tasaki, Y., Makino, Y., Ohta, S., and Hirobe, M., 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian brain. J. Neurochem., 65, 2633-2638 (1995) https://doi.org/10.1046/j.1471-4159.1995.65062633.x
  9. Lee, J.J., Kim, Y.M., Yin, S.Y., Park, H.D., Kang, M.H., Hong, J.T., and Lee, M.K. Tetrahydropapaveroline aggravates L-DOPA-induced neurotoxicity in PC12 cells. Biochem. Pharamacol., 66, 1787-1795 (2003) https://doi.org/10.1016/S0006-2952(03)00421-0
  10. Lee, M.K., Zhang, Y.H., Shin, J.S., and Lee, S.S., Inhibition of tyrosine hydroxylase by hydrastine. Med. Sci. Res., 25, 619-620 (1997)
  11. McNaught, K. St. P., Carrupt, P.A., Altmore, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P., and Marsden, C.D., Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinsons disease. Biochem. Phannacol., 56, 921-933 (1998) https://doi.org/10.1016/S0006-2952(98)00142-7
  12. Makino, Y., Ohta, S., Tachikawa, O., and Hirobe, M., Presence of tetrahydroisoquinoline and l-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson's disease. Life Sci., 43, 373-378 (1988) https://doi.org/10.1016/0024-3205(88)90115-4
  13. Marsden, C.D., Parkinson's disease. J. Neurol. Neruosurg. Psychiatry., 57, 672-681 (1994)
  14. Maruyama, W., Abe, T., Tohgi, H., Dostert, P., and Naoi, M., A dopaminergic neurotoxin, (R)-N-methylsalsolinol increases in parkinsonian cerebrospinal fluid. Ann. Neurol., 40, 119-122 (1996) https://doi.org/10.1002/ana.410400120
  15. Mosman, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immun. Meth., 65, 55-63 (1983) https://doi.org/10.1016/0022-1759(83)90303-4
  16. Nagatsu, T., and Hirata, Y., Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP$^+$) and the structurally related compounds in vitro and in vivo. Eur. Neurol., 26 (Suppl 1), 11-15 (1997)
  17. Ohta, S., Isoquinolines in Parkinson's disease. In: Storch, A., Collins, M.A., editors. Neurotoxic factors in Parkinson's disease and related disorders. New York Plenum Press, 3, 33-42 (2000)
  18. Perry, T.L., Yong, V.W., Ito, M., Foulks, J.D., Wall, R.A., Godin, D.V., and Clavier, R.M., Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J. Neurochem., 43, 990-993 (1984) https://doi.org/10.1111/j.1471-4159.1984.tb12834.x
  19. Przedborski, S., and Vila, M., MPTP: A review of its mechanisms of neurotoxicity. Clin. Neurosci. Res., 1, 407-418 (2001) https://doi.org/10.1016/S1566-2772(01)00019-6
  20. Rosenberg, P.A., Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci., 8, 2887-2894 (1988)
  21. Rossor, M.N., Watkins, J., Brown, M.J., Reid, J.L., and Dollery, C.T., Plasma levodopa, dopamine and therapeutic response following levodopa therapy of parkinsonian patients. Brain Res., 46, 385-392 (1980)
  22. Sandstrom, P.A., Mannie, M.D., and Buttke, T.H., Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol., 55, 221-226 (1994) https://doi.org/10.1002/jlb.55.2.221
  23. Tasaki, Y., Makino, Y., Ohta, S., and Hirobe, M., 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem., 57, 1940-1943 (1991) https://doi.org/10.1111/j.1471-4159.1991.tb06407.x